Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -245.10K | -2.15M | -487.80K | -695.80K | -376.40K |
| Total Depreciation and Amortization | 8.10K | 8.20K | 8.20K | 8.30K | 8.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.50K | 1.73M | 28.10K | 7.90K | -30.70K |
| Change in Net Operating Assets | 99.80K | 243.30K | 41.20K | 221.80K | 43.30K |
| Cash from Operations | -126.70K | -169.30K | -410.30K | -457.80K | -355.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 31.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -93.60K |
| Cash from Investing | -- | 31.00K | 0.00 | 0.00 | -93.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 151.60K | 129.90K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 117.60K | 102.20K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -3.10K | -40.00K | 4.40K | 2.30K | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.30K | -76.10K | -406.00K | -455.50K | -449.30K |